Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 3/22/15  and contains information from public web pages and contributions from the ZoomInfo community.

Mr. Kevin P. Starr

Wrong Kevin P. Starr?


Third Rock Ventures LLC
29 Newbury Street
Boston , Massachusetts 02116
United States

Company Description: At Third Rock we seek bold ideas and new frontiers that will pave the way for disruptive technologies and science which promise to dramatically improve the lives of...   more

Employment History

Board Memberships and Affiliations


  • Master of Science degree , Corporate Finance
    Boston College
  • Bachelor of Arts degree , Mathematics and Business
    Colby College
  • M.S. , Corporate Finance
    Boston College
  • B.A. , Mathematics and Business
    Colby College
  • MBA training
    Boston College
118 Total References
Web References
Agios, 22 Mar 2015 [cached]
Kevin Starr Third Rock Ventures
Mr. Starr has served as a member of our board of directors since June 2008. Since April 2007, Mr. Starr has been a Partner of Third Rock Ventures, a venture capital firm. From January 2003 to March 2007, Mr. Starr was an entrepreneur. From December 2001 to December 2002, Mr. Starr served as chief operating officer of Millennium. He also served as Millennium's chief financial officer from December 1998 to December 2002. Mr. Starr currently serves on the board of directors of Alnylam. Mr. Starr also serves on the boards of Zafgen, Inc., PanOptica, Inc., MyoKardia, Inc., Global Blood Therapeutics, Inc., Afferent Pharmaceuticals, and SAGE Therapeutics. Mr. Starr received an M.S. in corporate finance from Boston College and a B.A. in mathematics and business from Colby College.
Board of Directors – Alnylam, 29 May 2014 [cached]
Kevin Starr, Partner
Third Rock Ventures; interim CEO of Agios Pharmaceuticals (a portfolio company of Third Rock).; former Chief Operating Officer and Chief Financial Officer of Millennium Pharmaceuticals, Inc.; former Corporate Controller of Biogen, Inc. (now Biogen Idec, Inc.)
MyoKardia, 11 July 2014 [cached]
Kevin Starr
Kevin Starr is a proven operational leader with more than 25 years of experience building and operating leading biotech companies. Mr. Starr co-founded Third Rock Ventures in 2007 and focuses on the formation, development and business strategy of the firm's portfolio companies as well as actively identifying and evaluating new investments. In addition to his role at Third Rock, he also serves as the interim chief executive officer of SAGE Therapeutics. Prior to Third Rock Ventures, Mr. Starr was chief operating officer and chief financial officer at Millennium Pharmaceuticals, where he led key roles in raising billions of dollars in capital through strategic alliances and public financing and driving growth through company expansion and mergers and acquisitions. Earlier in his career, he served in various executive roles at Millennium BioTherapeutics, Biogen and Digital Equipment Corporation. He is currently a board member of Alnylam Pharmaceuticals and SAGE Therapeutics.
Mr. Starr holds a M.S. in corporate finance from Boston College and a B.A. in mathematics and business from Colby College.
Kevin ..., 3 Sept 2014 [cached]
Kevin Starr
Kevin Starr
Mr. Starr serves as partner at Third Rock Ventures, a venture capital fund whose passion is the creation and building of valuable and transformational life science companies that show high growth potential and are well-positioned to make a difference in the marketplace. Mr. Starr has more than 20 years of experience in management of finance, technology and operations in biotech. As chief operating officer and chief financial officer of Millennium, Mr. Starr led the business teams responsible for raising several billion dollars through partnerships and equity offerings. Mr. Starr has held leadership positions at Biogen, and he serves on the board of directors for several leading biotech companies.
Afferent Pharmaceuticals Names Bruce G. McCarthy, M.D., as CEO - PMD, 26 Jan 2010 [cached]
Kevin Starr, chairman of Afferent's Board of Directors and partner, Third Rock Ventures commented, “We are in the midst of building a leading new company in the pain management space.
Other People with the name "Starr":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.